Vox-MMSD: Voxel-wise Multi-scale and Multi-modal Self-Distillation for Self-supervised Brain Tumor Segmentation.

Journal: IEEE journal of biomedical and health informatics
Published Date:

Abstract

Many deep learning methods have been proposed for brain tumor segmentation from multi-modal Magnetic Resonance Imaging (MRI) scans that are important for accurate diagnosis and treatment planning. However, supervised learning needs a large amount of labeled data to perform well, where the time-consuming and expensive annotation process or small size of training set will limit the model's performance. To deal with these problems, self-supervised pre-training is an appealing solution due to its feature learning ability from a set of unlabeled images that is transferable to downstream datasets with a small size. However, existing methods often overlook the utilization of multi-modal information and multi-scale features. Therefore, we propose a novel Self-Supervised Learning (SSL) framework that fully leverages multi-modal MRI scans to extract modality-invariant features for brain tumor segmentation. First, we employ a Siamese Block-wise Modality Masking (SiaBloMM) strategy that creates more diverse model inputs for image restoration to simultaneously learn contextual and modality-invariant features. Meanwhile, we proposed Overlapping Random Modality Sampling (ORMS) to sample voxel pairs with multi-scale features for self-distillation, enhancing voxel-wise representation which is important for segmentation tasks. Experiments on the BraTS 2024 adult glioma segmentation dataset showed that with a small amount of labeled data for fine-tuning, our method improved the average Dice by 3.80 percentage points. In addition, when transferred to three other small downstream datasets with brain tumors from different patient groups, our method also improved the dice by 3.47 percentage points on average, and outperformed several existing SSL methods. The code is availiable at https://github.com/HiLab-git/Vox-MMSD.

Authors

  • Yubo Zhou
    Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan Tsuihang New District, Guangdong, 528400, PR China; School of Pharmacy, Zunyi Medical University, Zunyi, 563000, PR China; National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, PR China. Electronic address: ybzhou@simm.ac.cn.
  • Jianghao Wu
    Dongguan Guangming Ophthalmic Hospital, Dongguan, China.
  • Jia Fu
  • Qiang Yue
    Department of Radiology, West China Hospital of Sichuan University, Chengdu, China.
  • Wenjun Liao
    Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Shichuan Zhang
    Department of Radiation Oncology, Sichuan Cancer Hospital and Institute, University of Electronic Science and Technology of China, Chengdu, China.
  • Shaoting Zhang
  • Guotai Wang
    Wellcome / EPSRC Centre for Interventional and Surgical Sciences (WEISS), University College London, UK.

Keywords

No keywords available for this article.